UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

113 Uncovering the dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC): relevance for universal cancer vaccines, immunological monitoring and TIL therapy

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A125-A125

2022

Volltextzugriff (PDF)

148 Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A168-A168

2023

Volltextzugriff (PDF)

IL-3 and CTLA4 gene polymorphis.ms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients

Acta pharmacologica Sinica, 2017-03, Vol.38 (3), p.415-423

2017

Volltextzugriff (PDF)

443 An immunotherapy trio in advanced HNSCC for coordinated B and T cell antigen response

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A469-A469

2020

Volltextzugriff (PDF)

480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A296-A296

2020

Volltextzugriff (PDF)

680 Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A771-A771

2023

Volltextzugriff (PDF)

763 Initial results from phase I dose escalation trial of CAN1012 in patients with solid tumor malignancies

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A858-A858

2023

Volltextzugriff (PDF)

85 Detection of human angiotensin-converting enzyme 2 receptor (hACE2R) on human cancer cell lines

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A93-A93

2021

Volltextzugriff (PDF)

The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity

The Journal of biological chemistry, 1992-06, Vol.267 (18), p.12424-12427

1992

Volltextzugriff (PDF)

The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors

Oncology reports, 2008, Vol.19 (1), p.49-56

2008

Volltextzugriff (PDF)

Abstract 38: Development of a DC-targeted microvesicle vaccine to intercept the progression of oral preneoplasia to cancer

Clinical cancer research, 2017-12, Vol.23 (23_Supplement), p.38-38

2017

Volltextzugriff (PDF)

Abstract CT112: An off-the-shelf multivalent vaccine containing cancer’s dark matter, DPV-001, combined with PD-1 +/- GITR in head & neck cancer: safety, efficacy, and immunodynamics from the phase 1 GITRVax trial

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT112-CT112

2024

Volltextzugriff (PDF)

Abstract CT123: Trial in progress: First-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT123-CT123

2023

Volltextzugriff (PDF)

Abstract CT502: Preliminary immunological monitoring of first-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT502-CT502

2022

Volltextzugriff (PDF)

Accurate assessment of antibiotic susceptibility and screening resistant strains of a bacterial population by linear gradient plate

Science China. Life sciences, 2011-10, Vol.54 (10), p.953-960

2011

Volltextzugriff (PDF)

Acid-catalyzed intramolecular oxa-Michael addition reactions under solvent-free and microwave irradiation conditions

ARKIVOC free online journal of organic chemistry, 2009-01, Vol.2009 (14), p.146-155

2009

Volltextzugriff (PDF)

Acid-catalyzed intramolecular oxa-Michael addition reactions under solvent-free and microwave irradiation conditions

ARKIVOC, 2010, Vol.2009 (14)

2010

Volltextzugriff (PDF)

Actions speak louder than words: searching human action video based on body movement

Proceedings of the 20th ACM international conference on Multimedia, 2012, p.1261-1262

2012

Volltextzugriff (PDF)

Activating the Nucleic Acid-Sensing Machinery for Anticancer Immunity

International review of cell and molecular biology, 2019-01, Vol.344, p.173-214

2019

Volltextzugriff (PDF)

Active-specific immunotherapy for non-small cell lung cancer

Journal of thoracic disease, 2011-06, Vol.3 (2), p.105-114

2011

Volltextzugriff (PDF)

Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence

World journal of gastroenterology : WJG, 2014-08, Vol.20 (32), p.11384-11393

2014

Volltextzugriff (PDF)

Adjuvant Immunization of HLA-A2–Positive Melanoma Patients With a Modified gp100 Peptide Induces Peptide-Specific CD8+ T-Cell Responses

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1562-1573

2003

Volltextzugriff (PDF)

Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice

Journal of immunotherapy, 2010-10, Vol.33 (8), p.798-809

2010

Volltextzugriff (PDF)

Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cells

Journal of immunotherapy (1997), 2002-07, Vol.25 (4), p.359

2002

Volltextzugriff (PDF)

Adoptive Cellular Therapy With Tumor Vaccine Draining Lymph Node Lymphocytes After Vaccination With HLA-B7/β2-Microglobulin Gene-Modified Autologous Tumor Cells

Journal of immunotherapy (1997), 2002-07, Vol.25 (4), p.359-372

2002

Volltextzugriff (PDF)

1 – 25 von 585

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(499)
Mit Volltextzugriff
(520)

Publikationsform

Sprache

Englisch
(534)
Chinesisch
(58)
Japanisch
(52)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

113 Uncovering the dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC): relevance for universal cancer vaccines, immunological monitoring and TIL therapy

148 Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine

IL-3 and CTLA4 gene polymorphis.ms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients

443 An immunotherapy trio in advanced HNSCC for coordinated B and T cell antigen response

480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12

680 Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma

763 Initial results from phase I dose escalation trial of CAN1012 in patients with solid tumor malignancies

85 Detection of human angiotensin-converting enzyme 2 receptor (hACE2R) on human cancer cell lines

The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity

The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors

Abstract 38: Development of a DC-targeted microvesicle vaccine to intercept the progression of oral preneoplasia to cancer

Abstract CT112: An off-the-shelf multivalent vaccine containing cancer’s dark matter, DPV-001, combined with PD-1 +/- GITR in head & neck cancer: safety, efficacy, and immunodynamics from the phase 1 GITRVax trial

Abstract CT123: Trial in progress: First-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma

Abstract CT502: Preliminary immunological monitoring of first-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma

Accurate assessment of antibiotic susceptibility and screening resistant strains of a bacterial population by linear gradient plate

Acid-catalyzed intramolecular oxa-Michael addition reactions under solvent-free and microwave irradiation conditions

Acid-catalyzed intramolecular oxa-Michael addition reactions under solvent-free and microwave irradiation conditions

Actions speak louder than words: searching human action video based on body movement

Activating the Nucleic Acid-Sensing Machinery for Anticancer Immunity

Active-specific immunotherapy for non-small cell lung cancer

Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence

Adjuvant Immunization of HLA-A2–Positive Melanoma Patients With a Modified gp100 Peptide Induces Peptide-Specific CD8+ T-Cell Responses

Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice

Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cells

Adoptive Cellular Therapy With Tumor Vaccine Draining Lymph Node Lymphocytes After Vaccination With HLA-B7/β2-Microglobulin Gene-Modified Autologous Tumor Cells

Suchergebnisse filtern